ইস্রায়েল - ইংরেজি - Ministry of Health

rafa laboratories ltd - budesonide - capsules - budesonide 3 mg - budesonide - acute mild to moderate crohn’s disease with involvement of the ileum (twisted intestine) and/or ascending colon (part of large bowel). collagenous colitis.autoimmune hepatitis.

ইস্রায়েল - ইংরেজি - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - ziprasidone as hydrochloride monohydrate - capsules - ziprasidone as hydrochloride monohydrate 20 mg - ziprasidone - • schizophrenia. treatment of schizophrenia and for maintenance of clinical improvement during continuation therapy. • bipolar mania. ziprasidone is indicated as monotherapy in the treatment of manic or mixed episodes associated with bipolar disorder with or without psychotic features.• bipolar disorder. maintenance treatment of bipolar disorder, as an adjunct to lithium or valproate.

ইস্রায়েল - ইংরেজি - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - ziprasidone as hydrochloride monohydrate - capsules - ziprasidone as hydrochloride monohydrate 40 mg - ziprasidone - • schizophrenia. treatment of schizophrenia and for maintenance of clinical improvement during continuation therapy. • bipolar mania. ziprasidone is indicated as monotherapy in the treatment of manic or mixed episodes associated with bipolar disorder with or without psychotic features.• bipolar disorder. maintenance treatment of bipolar disorder, as an adjunct to lithium or valproate.

ইস্রায়েল - ইংরেজি - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - ziprasidone as hydrochloride monohydrate - capsules - ziprasidone as hydrochloride monohydrate 60 mg - ziprasidone - • schizophrenia. treatment of schizophrenia and for maintenance of clinical improvement during continuation therapy. • bipolar mania. ziprasidone is indicated as monotherapy in the treatment of manic or mixed episodes associated with bipolar disorder with or without psychotic features.• bipolar disorder. maintenance treatment of bipolar disorder, as an adjunct to lithium or valproate.

ইস্রায়েল - ইংরেজি - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - ziprasidone as hydrochloride monohydrate - capsules - ziprasidone as hydrochloride monohydrate 80 mg - ziprasidone - • schizophrenia. treatment of schizophrenia and for maintenance of clinical improvement during continuation therapy. • bipolar mania. ziprasidone is indicated as monotherapy in the treatment of manic or mixed episodes associated with bipolar disorder with or without psychotic features.• bipolar disorder. maintenance treatment of bipolar disorder, as an adjunct to lithium or valproate.

ইস্রায়েল - ইংরেজি - Ministry of Health

reckitt benckiser (near east) ltd - ibuprofen - capsules liquid filled - ibuprofen 200 mg - ibuprofen - relief of mild to moderate pain such as headache, toothache, menstrual pain, backache,muscular pain, anti-inflammatory for rheumatic diseases, reduction of fever.

ইস্রায়েল - ইংরেজি - Ministry of Health

novartis israel ltd - ciclosporin - capsules - ciclosporin 100 mg - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.

ইস্রায়েল - ইংরেজি - Ministry of Health

novartis israel ltd - ciclosporin - capsules - ciclosporin 25 mg - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.

ইস্রায়েল - ইংরেজি - Ministry of Health

novartis israel ltd - ciclosporin - capsules - ciclosporin 50 mg - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.

ইস্রায়েল - ইংরেজি - Ministry of Health

j-c health care ltd - ibrutinib - capsules - ibrutinib 140 mg - • mantle cell lymphoma:imbruvica is indicated for the treatment of adult patients with mantle cell lymphoma (mcl) who have received at least one prior therapy.• chronic lymphocytic leukemia/small lymphocytic lymphoma :imbruvica is indicated for the treatment of adult patients, with chronic lymphocytic leukemia (cll)/small lymphocytic lymphoma (sll)• chronic lymphocytic leukemia (cll) /small lymphocytic lymphoma (sll) with 17p deletion:imbruvica is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll) /small lymphocytic lymphoma (sll) with 17p deletion.• waldenström’s macroglobulinemiaimbruvica is indicated for the treatment of adult patients with waldenström’s macroglobulinemia (wm).• marginal zone lymphomaimbruvica is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who require systemic therapy and have received at least one prior anti-cd20-based therapy.• chronic graft versus host diseaseimbruvica is indicated for the treatment of adult patients with chronic graft-versus-host disease (cgvhd) after failure of one or more lines of systemic therapy.